-+ 0.00%
-+ 0.00%
-+ 0.00%
SSY Group Wins China Approval for Four Peritoneal Dialysis Solutions
Share
Listen to the news
SSY Group Wins China Approval for Four Peritoneal Dialysis Solutions
  • SSY Group secured Chinese regulatory approval to produce four bicarbonate-based peritoneal dialysis solutions for patients with chronic renal failure.
  • China's National Medical Products Administration also cleared arginine hydrochloride injection (200ml:20g) for emergency treatment of hyperammonemia.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SSY Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261119-12418145), on November 19, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending